
|Videos|July 23, 2017
Is Pseudoprogression in Lung Cancer Real?
Author(s)Dickran Kazandjian, MD
This video reviews pseudoprogression in non–small-cell lung cancer, including the incidence of this phenomenon and treatment considerations when it arises.
Advertisement
In this video, Dickran Kazandjian, MD, of the National Institutes of Health in Bethesda, Maryland, reviews pseudoprogression in non–small-cell lung cancer, including the incidence of this phenomenon, identifying pseudoprogression from true progression, and treatment considerations when it does arise.
Kazandjian gave a presentation on this subject at the 2017 American Society of Clinical Oncology (ASCO) Annual Meeting, held last month in Chicago.
Newsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on CancerNetwork
1
Frontline Sunvozertinib Improves PFS vs Chemotherapy in EGFR+ NSCLC
2
FDA Clears Investigator-Initiated IND for SRN-101 in Recurrent High-Grade Glioma
3
The Evolution of Artificial Intelligence in Oncology: Impact on Trials, Workflows, and Outcomes
4
Selinexor Combo Improves Spleen Volume Reduction in Myelofibrosis
5























































